Phenomenology of Functional Movement Disorders in Children
Objective: To study the phenomenology of Functional Movement Disorders (FMD) in children. Background: Data on FMD in children is sparse Method: The study included 13…Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia
Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers of the Valle del Cauca, Colombia, between 2020 and…Reliability and Validity of the English Version of the Parkinson Anxiety Scale
Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…Association between Stress and Bruxism in Egyptian University Female Students Throughout Their Final Exam Period
Objective: The Current study highlights the correlation between bruxism and stress in a group of Egyptian university students. Background: Bruxism is an involuntary contraction of…Angiotensin II Type 1 (AT1) receptor antagonists as potential candidates for anxiety treatment in Parkinson’s Disease
Objective: The aim of this study was to explore the effects of Angiotensin II Type 1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on…Effects of Motor Subtype Stability on Non-Motor Symptoms in Early Parkinson’s Disease
Objective: To determine the effects of motor subtypes’ stability on non-motor symptoms (NMS) over three years in early Parkinson’s disease (PD). Background: Research have found…Anxiety in Parkinson’s disease is associated with changes in brain structural connectivity
Objective: The aim of this study was to identify White Matter (WM) changes by comparing Parkinson's disease (PD) patients with and without anxiety, using diffusion-tensor…Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease
Objective: To assess the interplay of polygenic dopamine risk scores and psychiatric symptoms in the development of impulse control disorders (ICDs) in de novo patients…Psilocybin therapy for depression and anxiety associated with Parkinson’s disease: a pilot study (NCT04932434)
Objective: To investigate the safety, tolerability, feasibility, and preliminary efficacy of moderate and high dose psilocybin treatment with psychotherapeutic support for comorbid Parkinson's disease (PD)…The impact of anxiety symptoms and treatment on Parkinson’s disease-related disability: findings from the Parkinson’s Progression Markers Initiative
Objective: To determine the functional consequences of baseline anxiety symptoms and the longer-term impact of initiation of anxiety treatment in Parkinson’s disease (PD). Background: While…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 19
- Next Page »